Sam Thiagalingam

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

Jonathan D. Oliner, Jennifer A. Pietenpol, Sam Thiagalingam et al. · Nature · 1993 · 1.5K citations

Tumor Biology, Oncogenic Agent, Medicine +8

Is a p53-Regulated Inhibitor of G2/M Progression

Heiko Hermeking, Christoph Lengauer, Kornélia Polyák et al. · Molecular Cell · 1997 · 1.2K citations · Full text

Oncogenic forms of p53 inhibit p53-regulated gene expression

S E Kern, JA Pietenpol, Sam Thiagalingam et al. · Science · 1992 · 918 citations

Tumor Biology, Oncogenic Agent, Medicine +10

Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers

Sam Thiagalingam, Christoph Lengauer, Frederick S. Leach et al. · Nature Genetics · 1996 · 609 citations

Tumor Biology, Chromatin, Colorectal Cancers +11

Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder

Hamid M. Abdolmaleky, Kuang‐Hung Cheng, Stephen V. Faraone et al. · Human Molecular Genetics · 2006 · 458 citations · Full text

Major Risk Factor, Epigenetic Change, Genetics +19